Apogee Therapeutics News

Apogee Therapeutics | 8-K: Current report

Dec 10, 2024 20:35

Apogee Therapeutics | 8-K: Current report

Dec 2, 2024 19:20

Apogee Therapeutics | 8-K: Current report

Oct 24, 2024 20:13

Apogee Therapeutics | 8-K: Current report

Aug 19, 2024 19:32

Apogee Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Aug 13, 2024 05:31

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 13, 2024 04:06

Apogee Therapeutics | 8-K: Current report

Jun 8, 2024 04:10

Apogee Therapeutics | DEFA14A: Others

May 28, 2024 19:41

Apogee Therapeutics | 8-K: Current report

May 28, 2024 19:36

Apogee Therapeutics | 8-K: Current report

May 16, 2024 04:49

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 13, 2024 19:29

Apogee Therapeutics | DEF 14A: Definitive information statements

Apr 25, 2024 04:21

Apogee Therapeutics | DEFA14A: Others

Apr 25, 2024 04:20

Apogee Therapeutics | 8-K: Current report

Mar 25, 2024 19:33

Apogee Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

Mar 8, 2024 07:31

Apogee Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 6, 2024 05:09

Apogee Therapeutics | 8-K: Current report

Mar 5, 2024 21:17

Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 28, 2023 20:38

Apogee Therapeutics | 8-K: Current report

Aug 21, 2023 19:35

Apogee Therapeutics | 8-K: Current report

Aug 7, 2023 19:35